Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 4 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.

Implant slightly better than systemic therapy in noninfectious uveitis

08 Nov 2017

Fluocinolone acetonide implant and systemic corticosteroid therapy both improve vision-related quality of life (VRQoL) in patients with noninfectious uveitis, according to a study. However, the implant group shows an immediate improvement as compared to gradual for the systemic group.

Researchers evaluated semiannually data from the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) for the first 3 years after randomization. Participants involved patients with active or recently active intermediate uveitis, posterior uveitis or panuveitis enrolled in the Multicenter Steroid Treatment Trial and Follow-up Study.

Due to significant differences in the trajectories of VRQoL, analyses were stratified by assigned treatment (129 implants vs 126 systemic therapies). Generalized estimating equations were used to assess the impact of baseline measurements of visual function (visual acuity and visual field), demographics and disease characteristics.

After 3 years of follow-up, improvement in NEI-VFQ-25 scores was similar among participants in the implant group (11.9 points; 95 percent CI, 8.6 to 15.2; p<0.001) and the systemic group (9.0 points; 5.6 to 12.3; p<0.001; p=0.21 for interaction). Those in the implant group had a significant improvement during the first 6 months followed by stable scores. On the other hand, patients in the systemic group had a steady improvement over the course of follow-up.

Lower initial NEI-VFQ-25 scores correlated with worse initial visual acuity and visual fields for both treatment groups. Such differences persisted throughout follow-up among patients in the systemic group.

In the implant group, those with initial visual acuity worse than 20/40 showed further improvement in NEI-VFQ-25 score to come within ‒7 points (‒15.0 to 0.9) of those with visual acuity 20/40 or better initially. Such difference is clinically meaningful but not statistically significant (p=0.081). Furthermore, there were similar patterns in the results based on sensitivity analyses.

“Poorer visual function was associated significantly with initial differences in NEI-VFQ-25 scores. However, only individuals in the implant group with poor visual acuity were able to overcome their initial deficits by the end of 3 years,” researchers said.

Editor's Recommendations
Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 4 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.